- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
Small companies that have something that big companies want...
Posted on 4/7/14 at 11:01 am
Posted on 4/7/14 at 11:01 am
MCET is my latest investment. I wound up purchasing 100,000 shares @ $.0017/share. MCET has filed for a patent that is the first FDA approved cure for liver cancer. If patent is obtained refer to step 5: profit.
If MCET can obtain the patent I would imagine that a larger company would swoop in and either buy out this company altogether or purchase the patent. If either of these are done, what would happen to my shares? Do the larger companies purchase my shares also?
TIA
If MCET can obtain the patent I would imagine that a larger company would swoop in and either buy out this company altogether or purchase the patent. If either of these are done, what would happen to my shares? Do the larger companies purchase my shares also?
TIA
6
Posted on 4/7/14 at 11:12 am to TigerDik86
If that company had even a remote shot at bringing a cancer drug to the market then I can assure you it wouldn't be worth a whopping 6 million EV...
Posted on 4/7/14 at 11:28 am to TigerDik86
quote:
investment
Investment?
Posted on 4/7/14 at 11:33 am to TigerDik86
quote:
first FDA approved cure for liver cancer
whoa
Posted on 4/7/14 at 11:40 am to donRANDOMnumbers
Posted on 4/7/14 at 11:42 am to donRANDOMnumbers
If a big company bought out MCET, you would either get cash and/or shares of the big company doing the buyout. Either way, you would be getting P-A-I-D. I'm thinking about spending maybe $300 myself. Hate to call something so important a lottery ticket, but with MCET being so tiny, it's worth a chance.
Posted on 4/7/14 at 11:53 am to OnTheBrink
quote:
OnTheBrink
Low risk - High Reward Gamble?
Posted on 4/7/14 at 11:58 am to TigerDik86
quote:
Low risk - High Reward Gamble?
Getting there...
Posted on 4/7/14 at 12:24 pm to OnTheBrink
Is this an attempted patent on a naturally-occurring compound?
Posted on 4/7/14 at 2:30 pm to TigerDik86
quote:
first FDA approved cure for liver cancer
Press release says treatment. Subtle difference, but I'll research more on it and get back with you. If the prelim synopsis I just read is correct, it will be a unique therapy that will probably be used in conjunctions with other drugs, but it's NOT a cure. If the clinical data looks favorable, your stock could increase in value IF the patent is granted AND the FDA approves the therapy. If not, you just bet it all on red and Wesley Snipes came up.
Posted on 4/7/14 at 2:37 pm to jeepfreak
quote:
Wesley Snipes came up.
Passenger 57 came up?
Posted on 4/7/14 at 2:56 pm to TigerDik86
quote:
MCET has filed for a patent that is the first FDA approved cure for liver cancer.
You should probably do a bit of reading on the pre-clinical development process for biotech companies. That press release says they are still evaluating vsRNAs in "animal models", which is code for mice. Plus they are announcing they have just submitted a provisional application, which is to say they haven't even submitted the full application (they have a year to do so).
Long story short, small companies put out press releases like this all the time. I hope you put in more leg work than just reading the press release and glancing through the MCT website.
And they haven't cured liver cancer. They wouldn't even know if they had...they aren't running clinical trials. The most they can say is they have significantly affected liver cancer in mice.
Posted on 4/7/14 at 6:42 pm to Sigma
quote:We talkin' bout preclinical. We ain't talkin bout no Phase I or II or IV, we talkin about preclinical.
You should probably do a bit of reading on the pre-clinical development process for biotech companies.
As Sigma noted this is standard fare for tiny biotech firms with one or two candidates in their portfolio. Years away from Phase I (assuming it ever came close). OP should consider liquidating and going to the casino for optimal return on investment.
And a $170 position to top it off. Sigh.
This post was edited on 4/7/14 at 6:58 pm
Posted on 4/8/14 at 7:20 am to TigerDik86
What do you call penny stocks that aren't even worth a penny
Page 1 of 1
Back to top
Follow TigerDroppings for LSU Football News